Tumor immune tolerance is offered by the overexpression of immunosuppressive mediators, such as programmed cell death-ligand 1 (PD-L1), and by influencing the expression of cytotoxic T cells, natural killer (NK) cells. Here, CD274 is linked to neoplasm.